Although abnormal cell growth in arterial vessel walls underpins vascular remodeling in high blood pressure, the molecular basis of the abnormality in hypertension has not been fully defined. Here, we report that in the aorta of spontaneously hypertensive rats, telomerase is selectively activated and telomeres are lengthened, in vivo and in vitro. Down-regulation of telomerase, the ribonucleoprotein complex responsible for the maintenance and elongation of telomeres (the ends of chromosomes) arrests the increased proliferation of spontaneously hypertensive rat vascular smooth muscle cells and induces apoptosis. This apoptosis is reversible by overexpressing telomerase and is prevented by increasing p53 tumor suppressor protein expression and worsened by lowering p53. Telomerase activation, telomere maintenance, and the p53 checkpoint appear to be critical for increased vascular smooth muscle proliferation, thus they represent potential novel therapeutic targets in hypertension.
T he hallmark of chronic hypertension is vascular structural changes, including vessel wall hypertrophy and hyperplasia, which are major contributors to the elevated resistance in established hypertension, both genetic and experimental (reviewed in refs. [1] [2] [3] [4] . In spontaneously hypertensive rats (SHRs), a widely used model of human essential hypertension, vascular hypertrophy develops before any significant elevation in blood pressure, with increases in both the number and size of vascular smooth muscle cells (VSMCs) (5) (6) (7) (8) (9) (10) (11) (12) . Although the abnormal phenotype of VSMCs may reflect an imbalance of homeostasis in cell proliferative and apoptotic rates within the intimal space of the arterial vasculature (13) (14) (15) , little is known of the molecular mechanisms that underpin the complex processes of VSMC proliferation and apoptosis in SHRs (16) .
Analysis of cellular signaling pathways in the VSMCs of SHRs has revealed abnormalities in the actions of some hormones and growth factors. Expression of transforming growth factor-β1 (TGFβ1) and basic fibroblast growth factor (bFGF) is increased in SHR VSMCs; activation of the TGFβ1 receptor stimulates the growth response of SHR VSMCs and potentiates the proliferative effects of other growth factors in SHR VSMCs (17) . By stimulating the mitogenactivated protein kinase signaling pathway in SHR VSMCs, but not in normotensive WistarKyoto (WKY) VSMCs, insulin also up-regulates cell proliferation (18) . Angiotensin II (AII) stimulates c-Myc gene expression (19) and collagen production (20) in SHR VSMCs, promoting SHR VSMC growth and proliferation on one hand (20) (21) (22) , and suppressing VSMC apoptosis (15, 23) on the other. It has been suggested that VSMCs undergo increased apoptosis in SHRs, counterbalancing the increased proliferation and reflecting increased cell renewal and turnover rates (13-15, 21, 23) . Although the molecular genetic basis of the increased proliferation and apoptosis in SHR VSMCs remains to be clearly established, inhibition of AII receptors decreases the levels of Bcl-2 and increases Bax (15, 21, 23) . It is interesting that increased cell proliferation and increased cellular levels of c-Myc and Bcl-2 have been shown to be associated with increased telomerase activity and elongated telomeres in neoplastic cells (For reviews, see refs. 24 and 25).
Telomerase is composed of an RNA subunit and several protein components, including the catalytic subunit of telomerase (telomerase reverse transcriptase, or TERT) that plays a rate-limiting role in telomerase activity (26, 27) . Activation of telomerase prevents the telomere shortening inherent in chromosome replication, and/or elongates telomeres, thus resulting in a reset in the timing of cellular senescence toward immortalization, as typically seen in tumor cells (28) (29) (30) (31) (32) (33) (34) . Recent studies have shown that inhibition of telomerase is involved in the pathophysiology of degenerative as well as hyperplastic disease states (35, 36) . In dyskeratosis congenita, telomerase inhibition is associated with chromosome instability, apoptosis, and a predisposition to malignancy in fibroblasts and lymphoblasts (35) . Consistent with the human clinical syndrome, inhibition of telomerase in the mouse also leads to genomic instability, apoptosis, and defects in highly proliferative tissues (37, 38) . Moreover, telomerase dysfunction is associated with defects in liver regeneration and accelerates the development of liver cirrhosis in response to chronic liver injury in these mice (36) . Thus, telomerase appears to play an important role in regulating tissue regeneration and cell proliferation.
In this study, to assess the status of telomerase and telomeres, and their potential roles in genetic hypertension, we determined telomerase activity and telomere length in different tissues of normotensive and genetically hypertensive rats. We found that telomerase is selectively activated and telomeres are markedly elongated in the VSMCs of SHRs compared with control WKY VSMCs. In addition, inhibition of telomerase arrests increased SHR VSMC proliferation with increased apoptosis. Therefore, this study indicates that telomerase activation and telomere maintenance mediate the hyperproliferative phenotype of VSMCs in SHRs and, thus, that telomerase may play an obligatory role in the etiology of arterial vascular remodeling in genetic hypertension.
MATERIALS AND METHODS

Animals and aortic VSMC primary cultures
Male SHRs and WKY rats were obtained from colonies maintained at the Baker Medical Research Institute Biological Research Unit. The animals at various ages were subject to tissue collection and procedures in conformance with the guidelines of the National Health and Medical Research Council of Australia. Primary cultures of VSMCs were prepared by enzymatic dispersion of aortic media from 14-week-old SHRs and WKY rats as previously described (39) . The identity and purity of smooth muscle cells in the cultures were verified by immunocytochemical analysis, using antibodies for smooth muscle α-actin. The primary smooth muscle cells were subsequently passaged weekly, and cells after the fourth passage were used in all experiments, except for population doubling level analysis, as described previously (40) .
Expression construct preparation, VSMC transfection, immunofluorescent staining, and TdT-mediated dUTP-biotin nick end labeling (TUNEL)
TERT and p53 wild-type plasmids were prepared by subcloning full-length hTERT and mouse p53 cDNAs, respectively, into pcDNA3HA plasmids. TERT antisense expression vectors were generated by subcloning two hTERT cDNA fragments (1-2493 and 1-3399) into pcDNA3HA vectors in the antisense direction. We prepared p53 antisense expression plasmids by subcloning the full-length mouse p53 into pcDNA3HA in the antisense direction. All constructs were verified by restriction enzyme digestion and DNA sequencing. The empty vector control, wildtype, and antisense expression constructs were transfected into primary cultures of VSMCs at about 80% confluence with LipofectAMINE 2000 (6 µl/2 µg DNA/1 ml). After 24 h of incubation, cells were observed, examined for various changes, or subcultured at various densities for additional transfection or treatment as indicated in the legends of Figures 3 and 4 . For the treatment of VSMCs with staurosporine, VSMC cultures were treated with 0.5 µM staurosporine for 4 h. Immunofluorescent staining was performed, as described previously (41) , and TUNEL was carried out under standard protocols by incubating fixed and permeabilized VSMCs in the presence or absence of terminal transferase, fluorescein-dUTP, and tetramethylrhodamine-5-dUTP in the appropriate buffer. Positive and negative controls were included in each experiment.
Cellular fractionation, immunoblotting, telomerase activity assay, and telomere length analysis
Differential centrifugation was used to obtain total, nuclear, cytosolic, and membrane particulate fractions, and telomerase activity in each fraction was determined by telomeric repeat amplification protocol assay, as described previously (42, 43) . TERT protein expression was determined by immunoblotting with affinity-purified polyclonal anti-TERT, as described previously (43) . Expression of other proteins was determined by Western blotting, using antibodies against p53 (FL-393, sc-6243, Santa Cruz Biotechnology, Santa Cruz, CA), p21 (C-19, sc-397, Santa Cruz), Bax (BD Biosciences Pharmingen, San Diego, CA), Rb (IF-8, sc-102, Santa Cruz), PARP (Roche Molecular Biochemicals, Castle Hill, Australia), and ku (Chemicon, Temecula, CA). Telomere length was determined by extracting chromosome DNA and digesting it with the restriction enzymes Hinf1 (50 U) and Rsa1 (50 U) at 37°C overnight, followed by phenol/chloroform extraction and Southern blotting with radioisotope-labeled telomeric DNA as a probe, as described previously (44) .
RESULTS
Because telomerase and telomeres serve as important mechanisms regulating cell proliferation (28, (30) (31) (32) (33) , we analyzed telomerase activity and telomere size in various tissues of SHRs vs. WKY control rats. Telomerase activity in SHR aorta was twice that in WKY aorta, but not in other tissues examined (Fig. 1A) , and telomere abundance was four-to fivefold more in SHR aorta than in WKY aorta despite the heterogeneous distribution between 40 and 1 kb in both strains (Fig. 1B) . The increased activity in the aorta was found in animals 3-6 wk after birth (Fig.  1C) , well before the onset of hypertension. Immunoblotting also showed that expression of TERT was markedly increased in the aorta of immature SHRs (Fig. 1D) . Thus, the selective activation of telomerase in the aortic tissues of SHRs is not secondary to high blood pressure but presumably underlies vessel wall proliferation during the development of high blood pressure in genetic hypertension. This finding of telomerase activation in the arterial vessel walls is also consistent with and extends previous findings by providing in vivo evidence that telomerase upregulates cell proliferation without inducing transformation (45, 46) .
To explore why telomerase is activated and to characterize its cellular expression and possible function in aortic smooth muscle in SHRs, VSMCs from aortic media of SHRs and WKY rats aged 12 wk were prepared by enzymatic dispersion. To exclude any secondary influences of hypertension, cells were maintained in culture until passage 4 for use. Subcellular fractionation showed that telomerase activity was markedly elevated in the nuclei of SHR VSMCs compared with that in the nuclei of WKY rat VSMCs, despite a modest (and unexplained) decrease in activity in both strains in the presence of fetal calf serum ( Fig. 2A) . The increased telomerase activity persisted in SHR VSMCs when cells were cultured at a density ranging from ~20 to 100% confluence (not shown). Also consistent with the in vivo findings, the expression of TERT was significantly increased in SHR VSMCs compared with WKY rat VSMCs (Fig. 2B) . The increased TERT expression is consistent with previous findings of increased levels of the oncogenic transcription factor c-Myc (12, 17) in VSMCs of SHRs and that hypoxia stimulates telomerase activity and VSMC proliferative lifespan (47) .
Continuous observation of cultured VSMCs showed that both SHR and WKY rat VSMCs proliferated exponentially over a period of approximately 6 months. However, the SHR VSMCs proliferated at a significantly higher rate than those of WKY rats (Fig. 2C) . The similar levels of α-actin up to 120 passages suggest no significant contamination by other cell types or dedifferentiation of the cultured VSMCs (Fig. 2C inset) . This long-term observation is consistent with previous findings that SHR VSMCs produce higher cell numbers at a greater density, with a higher specific growth rate, particularly at a higher saturation density, than do WKY rat VSMCs (7-9, 11, 48) . Analysis of telomerase activity and telomere length in these cells showed that telomerase activity was consistently greater in the SHR VSMCs compared with WKY rat VSMCs (data not shown). Moreover, the telomeres were significantly longer in the SHR VSMCs than in the WKY rat VSMCs and were stabilized without progressive shortening up to 100 population doublings in both strains (Fig. 2D) . This suggests that the maintenance of telomeres is responsible for prolonged proliferation in both strains and that the increased telomerase activity and telomere size are required for the increased proliferative rate in SHR VSMCs. Immunofluorescent staining of cultured SHR VSMCs showed that at a relatively early stage of DNA damage in apoptotic cells, TERT was reduced in the nucleus (Fig. 2E, middle row) , and that at a later stage of apoptotic cells, TERT was completely lost in the nucleus (Fig. 2E, bottom  row) . Thus, these data support the hypothesis that increased telomerase activity and telomere size are required for the hyperproliferative status of VSMCs in genetically hypertensive animals and that inhibition of the activity and size may hinder proliferation and induce cell aging and/or apoptosis.
To further explore the causal relationship between telomerase activation and VSMC hyperproliferation, TERT was over-and underexpressed and the effects on cell proliferation and apoptosis were determined in SHR VSMC cultures. Transient transfection of VSMCs with wildtype TERT expression vectors significantly increased TERT and telomerase activity; transfection with TERT antisense plasmids reduced both ( Fig. 3A and B) . Although no significant change in telomere length was observed between groups post-transfection (data not shown), significant cell death was observed in the cell cultures several hours after antisense RNA down-regulated TERT (Fig. 3C) . In addition, a significant decrease in cell numbers was recorded in the VSMC cultures at day 3, 4, and 5 after forced expression of TERT antisense RNA (Fig. 3D) . The incomplete inhibition of the increased proliferation of SHR VSMCs may be explained by the relatively low transfection efficiency (15-20%) in these cells (data not shown).
To determine specificity of the cell death via apoptosis, cell cultures with TERT being over-or underexpressed by differential transfection were examined by TUNEL and DNA staining. Sporadic apoptosis was observed in the cell cultures at 24 h post-transfection with TERT antisense RNA (Fig. 4A) . Furthermore, the chromosome instability in cells with reduced levels of TERT was also reflected by increased apoptosis in response to DNA-damaging agents. UV irradiation (Fig. 4B ) or oxidative insult with Fe 2+ (Fig. 4C ) or with the protein kinase inhibitor staurosporine (data not shown) induced apoptosis in control cells under these conditions, with apoptosis markedly increased in cells pretransfected with TERT antisense cDNAs to downregulate TERT (Fig. 4B, C) . The apoptosis induced by TERT down-regulation is specific in that cotransfection with TERT wild type abolished apoptosis (Fig. 4A-D) . Thus, down-regulation of the elevated telomerase causes a reduction in cell proliferation in association with increased genomic instability and susceptibility to apoptosis in the hyperproliferative SHR VSMCs. The findings that telomerase inhibition reverses the increased SHR VSMC proliferation, together with the findings that telomerase activation occurs before significant vascular wall remodeling and the onset of hypertension, strongly suggest that telomerase activation plays a causal role in SHR VSMC proliferation.
Because telomeres are consistently longer in SHR VSMCs than in WKY rat VSMCs (Fig. 2D) and inhibition of telomerase induces apoptosis within 24 h without affecting telomere length ( Fig. 3 and 4) , it is possible that telomerase regulates VSMC proliferation by both telomerelengthening-dependent and -independent mechanisms. To explore the potential involvement of other proteins in TERT down-regulation-induced apoptosis via telomere-lengtheningindependent mechanisms, we examined the cellular levels of several proteins implicated in regulating cell proliferation and found no significant change for p53, Rb, PARP, ku, and Bax following TERT down-regulation (data not shown). Given that the tumor suppressor protein p53 mediates apoptosis induced by telomere impairment in other systems (49, 50), we also determined whether or not p53 plays a part in SHR VSMC apoptosis induced by TERT downregulation by over-or underexpressing p53 before inducing apoptosis by lowering TERT. Transfection of SHR VSMCs with wild-type p53 and with p53 mRNA antisense expression plasmids resulted in increased and decreased cellular levels of p53, respectively (data not shown). Lowering p53 triggered apoptosis and enhanced the apoptosis induced by lowering TERT; increasing wild-type p53 unambiguously prevented the apoptosis induced by TERT antisense expression (Fig. 4D) . Thus, in SHR VSMC cultures, reducing either TERT or p53 similarly compromises the genomic integrity of SHR VSMCs, and overexpressing p53 effectively prevents the apoptosis initiated by lowering TERT.
These findings strongly suggest that malfunctioning of the p53 checkpoint is involved in telomerase-inhibition-induced apoptosis and that reintroduction of the wild-type p53 may rescue the apoptotic cells by allowing DNA repair or/and balancing telomerase-induced chromosomal instability. The latter possibility of an interplay between telomerase and p53 is consistent with previous findings that p53 interacts with telomerase (25, 51) and safeguards genome integrity (52) . In addition, reinforcing the functional interaction between telomerase and p53 is the observation in breast cancer cells in which apoptosis induced by TERT down-regulation is also mimicked by p53 down-regulation and abolished by overexpressing p53 wild type (H. Li et al., unpublished observations). This suggests that SHR VSMCs resemble some neoplastic cells with increased telomerase activity, elongated telomeres, increased c-Myc and a deregulated p53 checkpoint in association with increased cellular proliferation.
DISCUSSION
Increased telomerase activity and telomere length observed both in vivo and in vitro are likely to play a causal role in the abnormally increased proliferation of VSMCs in genetically hypertensive animals. Because telomerase activation occurs before the onset of hypertension and telomerase inhibition reverses increased proliferation, increased telomerase activity appears to be the driving force for the imbalance between cell proliferation, senescence, and apoptosis, which ultimately results in the vascular wall remodeling seen in genetic hypertension. Molecular targeting of the increased activity may thus provide a window of opportunity to prevent high blood pressure.
This study also provides evidence for an action of telomerase over and above telomere lengthening to regulate cell proliferation and apoptosis in the genetically hypertensive rat. This telomere-lengthening-independent activity of telomerase in regulating VSMC proliferation may involve molecular regulation of telomere secondary/tertiary structure and chromosome integrity during cell division, in which cross-talk with the p53 pathway plays a part. Thus, telomerase may play multiple roles not only in up-regulating cell proliferative lifespan (or the timing of cell senescence) by stabilizing or/and elongating critically shortened telomeres (53) (54) (55) , but also in supporting cell proliferative rate (or the rate of cell renewal) by a mechanism involving telomerelengthening-independent activity.
In conclusion, the data presented in this report constitute the first evidence that telomerase activation is involved in genetic hypertension in SHRs by up-regulating VSMC proliferation. The finding that reducing TERT expression and telomerase activity arrests the increased proliferation of SHR VSMCs suggests a previously unexplored avenue for manipulating VSMC proliferation, serving as a potential point of departure for novel antihypertensive treatment. increased selectively in the aorta of SHRs. Telomerase activity was measured in cleared homogenates of tissues from SHRs (solid bar) and Wistar-Kyoto (WKY) rats (hatched bar) maintained under standard conditions by slightly modified telomeric repeat amplification protocol assay, with de novo synthesized telomeric DNA being purified before polymerase chain reaction amplification (42, 43) . Activities are expressed as the percentage of the activity in the testis, and each point represents the mean ± SD of triplicate or quadruplicate samples. The asterisk indicates significant difference in telomerase activities between SHR and WKY rat aortic tissues (P<0.01). B) Telomere sizes are greater in the aorta of SHRs than in that of WKY rats. Equal amounts of chromosomal DNA from individual aortas of SHRs and WKY rats were digested with the enzymes Hinf1 and Rsa1 and separated by electrophoresis (not shown). The digested DNAs were probed with from spontaneously hypertensive rats (SHRs). A) Subcellular fractionation and telomerase activity analysis in VSMCs from SHRs and Wistar-Kyoto (WKY) rats. To localize the increased telomerase activity in SHR aorta, aortic VSMCs were fractionated and telomerase activity in total lysates (lanes 2-5), cytosol (lanes 6-9), membrane particulate fraction (lanes 10-13), and nucleus (lanes 14-17) was measured by telomeric repeat amplification protocol. B) The increase in telomerase activity is associated with increased expression of telomerase reverse transcriptase (TERT) in cultured SHR VSMCs. Different amounts of solubilized proteins from SHR (lanes 2-5) and WKY rat (lanes 6-9) VSMCs were examined for telomerase activity (top panel) and TERT expression (middle panel), with α-actin being used as loading controls (bottom panel). C) VSMCs from SHRs and WKY rats proliferate constantly at different rates. The primary smooth muscle cells were passaged weekly, and cell population doubling level (PDL) was analyzed as a function of various culture days. The inset shows similar levels of VSMC-specific α-actin from WKY rats and SHRs over 120 passages. D) Telomeres are significantly longer in SHR VSMCs than in WKY rat VSMCs and are stabilized in both strains up to 100 PDL. Note: Increased telomere hybridization signals at increased average size were observed in SHR VSMCs (even-numbered lanes) compared with WKY rat VSMCs (odd-numbered lanes). Telomeres from breast cancer MCF7 (lanes 15 and 16) and PMC42 (lanes 17 and 18) cells are also shown as controls. E) Reduced expression of TERT is associated with apoptosis. Immunofluorescent staining of TERT and TdT-mediated dUTP-biotin nick end labeling (TUNEL) (41) of apoptotic cells in SHR VSMCs showed decreases of TERT in apoptotic cells. TERT is stained red, α-actin is green in cytoplasm, broken DNA is green in the nucleus, and total DNA is blue. Arrows indicate the positive staining with TUNEL, reduced TERT in the nucleus, and DNA staining of the apoptotic cells. hypertensive rat (SHR) vascular smooth muscle cell (VSMC) cultures. SHR VSMCs were transfected with empty vector or TERT antisense constructs or were cotransfected with TERT wild type for 15 h followed by transfection with TERT antisense constructs. TdT-mediated dUTP-biotin nick end labeling (TUNEL) was performed after 24 h of the transfection to detect apoptotic cells (green staining, top); DNA is stained blue (bottom). B) Down-regulation of TERT induces increased sensitivity of SHR VSMCs to UV irradiation-induced apoptosis. SHR VSMCs were exposed to UV light for 15 s, as described previously (39) , after transfection, as described in Figure 4A . Apoptosis was then detected by TUNEL. C) Quantification of apoptosis. SHR VSMCs were transfected with various control and TERT antisense and wild-type expression constructs and were then treated with or without different apoptotic-inducing factors. The treated cells were examined by TUNEL, and positive cells, with stained nuclear DNA, were counted under the microscope to determine the total population. Percentages of apoptotic cells are presented, and data are means ± SD of three similar experiments with at least four fields from each slide counted. D) Down-regulation of p53 mimics, and up-regulation of p53 prevents, the SHR VSMC apoptosis induced by telomerase down-regulation. To determine a potential role of p53 in TERT down-regulationinduced apoptosis, SHR VSMCs were transfected with or without different plasmids for 24 h. They were then washed and transfected again with various constructs. Cell death was examined and photographed under the phase-contrast microscope. Data presented are from one of several experiments.
